-
Only 1% of R&D Funds Spent for HIV, Tuberculosis and Malaria: WHO
Investments in health research and development (R&D) are poorly aligned with global public health needs, the World Health Organisation said, highlighting that merely 1% of the total funding on health R&D was allocated towards neglected diseases like HIV , tuberculosis and malaria which account for more than 12.5% of the global disease burden.
- Categories
- Health Care
-
University Students in Bolivia Create Chip That Helps Detect Tuberculosis
Two Bolivian university students have created a chip for microscopes that automatically detects tuberculosis in sputum samples, a procedure that in Bolivia and other developing countries is normally done with not always accurate bacilloscopy.
- Categories
- Health Care
- Region
- Latin America
-
Eli Lilly Plans $90 Million Investment to Improve Health Care in Poor Areas
Eli Lilly and Co. wants to improve access to health care for 30 million people in impoverished areas across the world.
- Categories
- Health Care, Investing
-
Global Health: Longer Lives, More Lifestyle Disease
Life expectancy worldwide has jumped by a decade since 1980, rising in 2015 to 69 years for men and nearly 75 for women, according to a comprehensive overview of global health released Thursday.
- Categories
- Health Care
-
Child TB Deaths Set to Fall as Kenya Launches New Drugs
More children are likely to survive tuberculosis, the leading infectious disease killer, after Kenya introduces child-friendly medicines on Oct. 1 - the first country in the world to do so.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
South Africa’s Outdated Patent Laws Are Standing in the Way of Affordable, Lifesaving Drugs
The drug used to treat hepatitis B costs more than 10 times as much in South Africa as it does in India. Protests in Pretoria on Sept. 27 sought to highlight the exorbitant prices of many lifesaving drugs in the country. They lay the blame on medical patent laws that allow drug companies to charge full price for medication that can be purchased for much less in other parts of the world. The hepatitis B treatment, for instance, costs about $400 in South Africa, compared to just $35 in India.
-
Billion dollar funding package agreed for universal health coverage in Africa
The World Bank and the Global Fund will invest $24bn in Africa over the next three to five years in order to accelerate universal health coverage across the continent. The bank and the fund, which works to tackle AIDS, TB and malaria, announced the funding at a Japanese-backed conference on African development in Kenya last week.
- Categories
- Health Care, Impact Assessment
- Region
- Sub-Saharan Africa
-
Research charities help marry two major South African HIV/tuberculosis institutes
As the International AIDS Conference kicked off in Durban, South Africa, today, two of the nation’s most prominent biomedical research institutions announced that they will marry and combine resources to attack the raging coepidemic of tuberculosis (TB) and HIV in the region.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
Parent Organization
